Therefore, further research into the relationship between insulin, leptin, and NAFLD stages is crucial for improving diagnostic and predictive approaches and ultimately alleviating the healthcare burden associated with advanced liver disease. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.